637 related articles for article (PubMed ID: 8886119)
21. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis.
Kodym P; Machala L; Rohácová H; Sirocká B; Malý M
Clin Microbiol Infect; 2007 Jan; 13(1):40-7. PubMed ID: 17184286
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of a dot-blot technique for the detection of Epstein-Barr virus antibodies (IgG anti-viral capsid antigen)].
Bouillet L; Cattoen C; Keilani A; Chatelain C; Mazars E
Ann Biol Clin (Paris); 1998; 56(1):79-83. PubMed ID: 9754226
[TBL] [Abstract][Full Text] [Related]
23. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
Obel N; Høier-Madsen M; Kangro H
APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
[TBL] [Abstract][Full Text] [Related]
24. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
Nadala EC; Tan TM; Wong HM; Ting RC
J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
[TBL] [Abstract][Full Text] [Related]
25. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
Andersson A; Vetter V; Kreutzer L; Bauer G
J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.
Sener AG; Afsar I; Pinar E
J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
[TBL] [Abstract][Full Text] [Related]
28. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
30. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
Kaschka WP; Hilgers R; Skvaril F
Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
[TBL] [Abstract][Full Text] [Related]
31. Serological evidence for active Epstein-Barr virus infection in multifocal choroiditis.
Bhende PS; Biswas J; Madhavan HN
Indian J Pathol Microbiol; 1997 Apr; 40(2):129-31. PubMed ID: 9257497
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
[TBL] [Abstract][Full Text] [Related]
33. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
34. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
35. [Study on the serological diagnosis of Epstein-Barr virus among patients with mononucleosis].
Liu CY; Yan J; Liu YY; Xie ZD
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Sep; 28(9):898-900. PubMed ID: 18251276
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
37. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
38. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
Seigneurin JM; Kressmann MC; Lavoué MF; Saez G; Lenoir G
Nouv Presse Med; 1978 Dec; 7(44):4005-10. PubMed ID: 215969
[TBL] [Abstract][Full Text] [Related]
39. Compact Epstein-Barr virus diagnosis based on a defined antigen mix and specific IgA.
Dopatka HD; Schuy W
Res Virol; 1996; 147(1):53-66. PubMed ID: 8882341
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus serology in patients with autoimmune thyroiditis.
Vrbikova J; Janatkova I; Zamrazil V; Tomiska F; Fucikova T
Exp Clin Endocrinol Diabetes; 1996; 104(1):89-92. PubMed ID: 8750577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
